More than 65 institutional investors are urging the directors of companies making Covid-19 vaccines to tie executive compensation to vaccine equity in hopes of holding management “accountable” for contributing to a global health problem.
In a series of letters, the investors asked the heads of the board compensation committees at Pfizer (PFE), Johnson & Johnson (JNJ), Moderna (MRNA), and AstraZeneca (AZN) to adopt goals outlined recently by the World Health Organization to ensure 70% of the global population is vaccinated by the end of 2022.
About the Author Reprints
Create a display name to comment
This name will appear with your comment
